. Ncd-risc, Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants, Lancet, vol.389, issue.16, p.27863813, 2017.

A. V. Chobanian and . Shattuck-lecture, The hypertension paradox-more uncontrolled disease despite improved therapy. The New England journal of medicine, vol.361, pp.878-87, 2009.

T. Beaney, A. E. Schutte, M. Tomaszewski, C. Ariti, L. M. Burrell et al., Measurement Month 2017: an analysis of blood pressure screening results worldwide. The Lancet Global health, vol.6, p.29778399, 2018.

M. M. Ibrahim and A. Damasceno, Hypertension in developing countries, Lancet, vol.380, issue.9841, p.22883510, 2012.

T. J. Bramley, P. P. Gerbino, B. S. Nightengale, and F. Frech-tamas, Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations, Journal of managed care pharmacy: JMCP, vol.12, issue.3, p.16623608, 2006.

R. Chowdhury, H. Khan, E. Heydon, A. Shroufi, S. Fahimi et al., Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences, European heart journal, vol.34, issue.38, 2013.

H. B. Bosworth, B. B. Granger, P. Mendys, R. Brindis, R. Burkholder et al., Medication adherence: a call for action, American heart journal, vol.162, issue.3, p.21884856, 2011.

D. M. Cutler and W. Everett, Thinking outside the pillbox-medication adherence as a priority for health care reform, vol.362, 2010.

L. Osterberg and T. Blaschke, Adherence to medication. The New England journal of medicine, vol.353, pp.487-97, 2005.

. Who, Adherence to Long-term Therapies: Evidence for action

, World Health Organization, 2003.

T. A. Gaziano, Cardiovascular disease in the developing world and its cost-effective management, Circulation, vol.112, issue.23, p.16330695, 2005.

R. B. Haynes, H. Mcdonald, A. X. Garg, and P. Montague, Interventions for helping patients to follow prescriptions for medications. The Cochrane database of systematic reviews, p.12076376, 2002.

N. K. Choudhry, Improving the pathway from cardiovascular medication prescribing to longer-term adherence: new results about old issues, Circulation Cardiovascular quality and outcomes, vol.3, issue.3, p.20484200, 2010.

A. Dragomir, R. Cote, L. Roy, L. Blais, L. Lalonde et al., Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs, Medical care, vol.48, issue.5, p.20393367, 2010.

J. O. Nielsen, A. D. Shrestha, D. Neupane, and P. Kallestrup, Non-adherence to anti-hypertensive medication in low-and middle-income countries: a systematic review and meta-analysis of 92443 subjects, Journal of human hypertension, vol.31, issue.1, p.27306087, 2016.

M. Antignac, I. B. Diop, M. De-terline, D. Kramoh, K. E. Balde et al., Socioeconomic Status and Hypertension Control in Sub-Saharan Africa: The Multination EIGHT Study (Evaluation of Hypertension in Sub-Saharan Africa). Hypertension (Dallas, Tex: 1979), vol.71, p.29378852, 2018.

E. Marijon, P. Ou, D. S. Celermajer, B. Ferreira, A. O. Mocumbi et al., Prevalence of rheumatic heart disease detected by echocardiographic screening. The New England journal of medicine, vol.357, pp.470-476, 2007.

B. Ranque, A. Menet, I. B. Diop, V. Thiam, D. Diallo et al., Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study, Lancet Haematol, p.27030156, 2014.

M. Antignac, B. I. Diop, M. De-terline, D. Bernard, M. Do et al., Fighting fake medicines: First quality evaluation of cardiac drugs in Africa, Int J Cardiol, vol.243, p.28641892, 2017.

D. Macquart-de-terline, B. I. Diop, M. Bernard, B. Do, M. S. Ikama et al., Substandard drugs among five common antihypertensive generic medications: an analysis from 10 African countries, J Hypertens, p.28957849, 2017.

V. Korb-savoldelli, F. Gillaizeau, J. Pouchot, E. Lenain, N. Postel-vinay et al., Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults, Journal of clinical hypertension, vol.14, issue.7, p.22747615, 2012.

T. M. Abegaz, A. Shehab, E. A. Gebreyohannes, A. S. Bhagavathula, and A. A. Elnour, Nonadherence to antihypertensive drugs: A systematic review and meta-analysis, Medicine, vol.96, issue.4, p.28121920, 2017.

V. Kini and P. M. Ho, Interventions to Improve Medication Adherence: A Review, Jama, vol.320, issue.23, p.30561486, 2018.

A. D. Bowry, W. H. Shrank, J. L. Lee, M. Stedman, and N. K. Choudhry, A systematic review of adherence to cardiovascular medications in resource-limited settings, Journal of general internal medicine, vol.26, issue.12, p.21858602, 2011.

P. C. Rockers, R. O. Laing, P. G. Ashigbie, M. A. Onyango, C. K. Mukiira et al., Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial. The Lancet Global health, vol.7, p.30799142, 2019.

G. Bodeker, Lessons on integration from the developing world's experience. BMJ (Clinical research ed), vol.322, p.11159579, 2001.

D. Hollenberg, D. Zakus, T. Cook, and X. W. Xu, Re-positioning the role of traditional, complementary and alternative medicine as essential health knowledge in global health: do they still have a role to play? World health & population, vol.10, p.19550163, 2008.

. Who and . World, Health Organization Traditional Medicine Strategy, 2014.

E. Mills, S. Singh, K. Wilson, E. Peters, R. Onia et al., The challenges of involving traditional healers in HIV/AIDS care, International journal of STD & AIDS, vol.17, issue.6, pp.360-363, 2006.

A. Van-der-watt, G. Nortje, L. Kola, J. Appiah-poku, C. Othieno et al., Collaboration Between Biomedical and Complementary and Alternative Care Providers: Barriers and Pathways. Qualitative health research, vol.27, pp.2177-88, 2017.

B. Appiah, I. K. Amponsah, A. Poudyal, and M. Mensah, Identifying strengths and weaknesses of the integration of biomedical and herbal medicine units in Ghana using the WHO Health Systems Framework: a qualitative study. BMC complementary and alternative medicine, vol.18, p.30348173, 2018.

N. Kramer, F. Barasa, A. Damasceno, A. Dzudie, E. Jones et al., evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). The New England journal of medicine, vol.311, pp.507-527, 2014.

D. B. Ojji, B. Mayosi, V. Francis, M. Badri, V. Cornelius et al., Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans, p.30883050, 2019.

M. T. Pruijm, M. P. Maillard, and M. Burnier, Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine. Vascular health and risk management, vol.4, p.19337529, 2008.

T. M. Ruppar, J. M. Dunbar-jacob, D. R. Mehr, L. Lewis, and V. S. Conn, Medication adherence interventions among hypertensive black adults: a systematic review and meta-analysis, J Hypertens, vol.35, issue.6, p.28106662, 2017.

L. Shi, J. Liu, V. Fonseca, P. Walker, A. Kalsekar et al., Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health and quality of life outcomes, vol.8, p.20836888, 2010.

M. W. Attaei, R. Khatib, M. Mckee, S. Lear, G. Dagenais et al., Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middleincome, and low-income countries: an analysis of the PURE study data. The Lancet Public health, vol.2, p.29253412, 2017.

V. J. Wirtz, W. A. Kaplan, G. F. Kwan, and R. O. Laing, Access to Medications for Cardiovascular Diseases in Lowand Middle-Income Countries, Circulation, vol.133, issue.21, p.27217433, 2016.